Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The Potential of Circular RNAs as Biomarkers in Pulmonary Arterial Hypertension Related to Congenital Heart Disease.

Autor: Siregar, Fajri Marindra^1,2 (AUTHOR), Haryana, Sofia Mubarika³ (AUTHOR), Anggrahini, Dyah Wulan⁴ (AUTHOR), Dinarti, Lucia Kris⁴ (AUTHOR), Hartopo, Anggoro Budi⁴ (AUTHOR) a_bhartopo@ugm.ac.id

Publikováno v: Congenital Heart Disease. 2024, Vol. 19 Issue 4, p375-388. 14p.

Liver dysfunction and 18F-NAF atherosclerotic plaque uptake – Analysis in high-cardiovascular risk individuals

Autor: Santos, M., Castelo-Branco, M., Silva, R., Gomes, A., Donato, P., Ferreira, J., Domingues, C., Pego, M., Gonçalves, L., Ferreira, M.J.

Publikováno v: In Atherosclerosis September 2016 252:e190-e190

MicroRNA-424(322) as a new marker of disease progression in pulmonary arterial hypertension and its role in right ventricular hypertrophy by targeting SMURF1.

Autor: Baptista R; Department of Cardiology A, Centro Hospitalar e Universitário de Coimbra, 3000-001 Coimbra, Portugal.; CNC.IBILI, University of Coimbra, Coimbra, Portugal.; Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Azinhaga de Sta Comba, Celas, 3000-354 Coimbra, Portugal.; Faculty of Medicine, University of Coimbra, 3000-354 Coimbra, Portugal., Marques C; CNC.IBILI, University of Coimbra, Coimbra, Portugal.; Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Azinhaga de Sta Comba, Celas, 3000-354 Coimbra, Portugal.; Faculty of Medicine, University of Coimbra, 3000-354 Coimbra, Portugal., Catarino S; CNC.IBILI, University of Coimbra, Coimbra, Portugal.; Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Azinhaga de Sta Comba, Celas, 3000-354 Coimbra, Portugal.; Faculty of Medicine, University of Coimbra, 3000-354 Coimbra, Portugal., Enguita FJ; Instituto de Medicina Molecular, Faculty of Medicine, University of Lisbon, 1649-028 Lisboa, Portugal., Costa MC; Instituto de Medicina Molecular, Faculty of Medicine, University of Lisbon, 1649-028 Lisboa, Portugal., Matafome P; CNC.IBILI, University of Coimbra, Coimbra, Portugal.; Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Azinhaga de Sta Comba, Celas, 3000-354 Coimbra, Portugal.; Faculty of Medicine, University of Coimbra, 3000-354 Coimbra, Portugal.; Department of Complementary Sciences, Coimbra Health School (ESTeSC), Instituto Politécnico de Coimbra, 3046-854 Coimbra, Portugal., Zuzarte M; CNC.IBILI, University of Coimbra, Coimbra, Portugal.; Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Azinhaga de Sta Comba, Celas, 3000-354 Coimbra, Portugal.; Faculty of Medicine, University of Coimbra, 3000-354 Coimbra, Portugal., Castro G; Department of Cardiology A, Centro Hospitalar e Universitário de Coimbra, 3000-001 Coimbra, Portugal., Reis A; Unidade de Doença Vascular Pulmonar, Departamento de Medicina, Centro Hospitalar do Porto, EPE, 4099-001 Porto, Portugal., Monteiro P; Department of Cardiology A, Centro Hospitalar e Universitário de Coimbra, 3000-001 Coimbra, Portugal.; Faculty of Medicine, University of Coimbra, 3000-354 Coimbra, Portugal., Pêgo M; Department of Cardiology A, Centro Hospitalar e Universitário de Coimbra, 3000-001 Coimbra, Portugal., Pereira P; CNC.IBILI, University of Coimbra, Coimbra, Portugal.; Faculty of Medicine, University of Coimbra, 3000-354 Coimbra, Portugal.; CEDOC, NOVA Medical School, Nova University of Lisbon, 1169-056 Lisboa, Portugal., Girão H; CNC.IBILI, University of Coimbra, Coimbra, Portugal.; Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Azinhaga de Sta Comba, Celas, 3000-354 Coimbra, Portugal.; Faculty of Medicine, University of Coimbra, 3000-354 Coimbra, Portugal.

Publikováno v: Cardiovascular research [Cardiovasc Res] 2018 Jan 01; Vol. 114 (1), pp. 53-64.

Utilização de alguns marcadores (Enzima Conversora da Angiotensina, Neopterina, Hidroxiprolina e GA 67) no estudo da alveolite subclínica dos indivíduos expostos à inalação de asbesto

Autor: Baganha, M. F., Abreu, F., Marques, M. A. T., Macedo, M., Pêgo, M. A., Lima, M. A., Mesquita, L., Robalo Cordeiro, C., Mota-Pinto, A., Ferrer Antunes, A., Teixeira, M. L., Chieira, L., Alcobia, C., Sousa, A., Leite, I., Azevedo-Bernarda, R., Santos-Rosa, M., Morais, J. C. T., Robalo Cordeiro, A. J. A.

Publikováno v: Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP

Em publicações anteriores tivemos oportunidade de demonstrar que indivíduos submetidos à inalação profissional de fibras de asbesto podem desenvolver uma alveolite subclínica dependente da concentração parenquimatosa deste material, expressa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::09a9e0973f912fa30e18fadf39ac461f